Results 131 to 140 of about 6,720,136 (196)

Competing-risks regression in Stata 11 [PDF]

Competing-risks survival regression provides a useful alternative to Cox regression in the presence of one or more competing risks. For example, say that you are studying the time from initial treatment for cancer to recurrence of cancer in relation to ...
Roberto G. Gutierrez
core  

Cumulative incidence estimation in the presence of competing risks

When competing risks are present, the appropriate estimate of the failure probabilities is the cumulative incidence. stcompet creates new variables containing the estimate of this function, its standard error, and ln(-ln) transformed confidence bounds ...
May Boggess, Vincenzo Coviello
core  

Gastrointestinal bleeding in hepatocellular carcinoma under systemic therapy: Real-world incidence and clinical predictors. [PDF]

Clinics (Sao Paulo)
Da Fonseca LG, Ikeoka LT, Sampaio EK, da Silveira THM, Yamamoto VJ, de Melo MAZ, Hoff PM, Sabbaga J.   +7 more
europepmc   +1 more source

Cardiac surgery-associated AKI and the risk of progression to end-stage renal disease. A retrospective cohort study. [PDF]

Ren Fail
Hilska M, Toukola T, Wistbacka JO, Koivisto SP, Sarkkinen T, Pikkujämsä A.   +5 more
europepmc   +1 more source

Refracture or death after osteoporotic fracture: five-year competing-risk and multistate trajectories. [PDF]

Front Endocrinol (Lausanne)
Zhang Y, Li B, Li Z, Zheng Z, Zhao Y, Zhang X, Lu Q, Zhao Z, Wang P, Cui L, Zhang Y, Li M, Liu L.   +12 more
europepmc   +1 more source

Estimating and Projecting Efficacy of Monoclonal Antibodies Against Respiratory Syncytial Virus Beyond Clinical Trial Periods. [PDF]

Vaccines (Basel)
Wang D, Lang JC, Kura K, Chen YH.
europepmc   +1 more source

Frailty and low body mass index as key determinants of sodium-glucose cotransporter 2 inhibitor-specific adverse event-related discontinuation in adults aged ≥75 years: A multicenter real-world retrospective cohort study. [PDF]

J Diabetes Investig
Uchida T, Ueno H, Konagata A, Nabekura H, Kikuchi Y, Beppu T, Sekishima A, Sekishima H, Nakamura T, Kogo F, Uehira Y, Tanaka Y, Yamaguchi H, Shimoda K.   +13 more
europepmc   +1 more source

Immune Checkpoint Inhibitor Therapy and Risk of Glomerular Disease: A Large Propensity-Matched Cohort Study. [PDF]

Life (Basel)
Tsai PH, Chang WC, Jhou HJ, Chen HY, Kao LT, Hsieh TY, Chen PH, Lee CH.   +7 more
europepmc   +1 more source

Acute kidney injury in Staphylococcus aureus bacteraemia: a multicentre cohort study of incidence, timing, recovery and associations with antibiotic treatment. [PDF]

J Antimicrob Chemother
Sinkeler FS, Kouijzer IJE, Jager NGL, Ten Oever J, Leegwater E, Gisolf J, Reuling D, Spoel ZM, Hensgens MPM, Brüggemann RJ.   +9 more
europepmc   +1 more source

Folic Acid Therapy is Associated with a Lower Risk of Incident Diabetes and Better Glycemic Status in Patients with Coronary Heart Disease: Findings from a Multicenter Propensity Score-Matched Analysis. [PDF]

Drug Des Devel Ther
Song S, Cai X, Li X, Cui P, Zou Z, Liu Y, Wang K, Li S.   +7 more
europepmc   +1 more source